Research programme: central nervous system disorder therapeutics - Amura
Latest Information Update: 06 Jul 2010
At a glance
- Originator Amura
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; CNS disorders; Cognition disorders
Most Recent Events
- 28 Aug 2006 Preclinical trials in Anxiety disorders in United Kingdom (unspecified route)
- 28 Aug 2006 Preclinical trials in CNS disorders in United Kingdom (unspecified route)
- 28 Aug 2006 Preclinical trials in Cognition disorders in United Kingdom (unspecified route)